Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4531 to 4545 of 7685 results

  1. E-cigarettes for harm reduction: Are nicotine-containing e‑cigarettes effective and safe for harm reduction when used alongside tobacco products to cut down on smoking (dual-use approach)?

    Recommendation ID NG209/06 Question E-cigarettes for harm reduction: Are nicotine-containing e‑cigarettes effective and safe for harm reduction

    Research recommendation
    Published
    17 December 2021

  2. Nicotine replacement therapy and e-cigarettes and pregnancy: Are nicotine replacement therapy or nicotine-containing e-cigarettes effective to help women stop smoking in pregnancy (and at what dose)?

    Recommendation ID NG209/02 Question Nicotine replacement therapy and e-cigarettes and pregnancy: Are nicotine replacement therapy or...

    Research recommendation
    Published
    17 December 2021

  3. Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and cost effective at increasing uptake of flu vaccination among front-line health and social care staff?

    Recommendation ID NG103/4 Question Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and

    Research recommendation
    Published
    12 December 2018

  4. Relapse prevention: Are NRT or nicotine-containing e‑cigarettes effective for preventing relapse after a successful quit attempt?

    Recommendation ID NG209/11 Question Relapse prevention: Are NRT or nicotine-containing e‑cigarettes effective for preventing relapse after

    Research recommendation
    Published
    17 December 2021

  5. Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after second-generation endometrial ablation for women with HMB associated with myometrial pathology (adenomyosis and/or uterine fibroids) equivalent to those for women without myometrial pathology?

    Recommendation ID NG88/5 Question Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after

    Research recommendation
    Published
    14 November 2018

  6. Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are

    Research recommendation
    Published
    21 October 2021

  7. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and

    Research recommendation
    Published
    21 October 2021

  8. Clinical trials should be conducted comparing ticagrelor with prasugrel in people with acute coronary syndromes (ACS).

    Recommendation ID TA236/1 Question Clinical trials should be conducted comparing ticagrelor with prasugrel in people with acute coronary

    Research recommendation
    Published
    9 June 2015

  9. Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life outcomes using validated scales. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG581/1 Question Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life

    Research recommendation
    Published
    12 October 2018

  10. Clinicians should enter details about all patients having selective internal radiation therapy (SIRT) for unresectable primary intrahepatic cholangiocarcinoma onto a suitable registry.

    Recommendation ID IPG630/2 Question Clinicians should enter details about all patients having selective internal radiation therapy (SIRT)

    Research recommendation
    Published
    18 December 2018

  11. Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life outcomes using validated scales. NICE may update the guidance on publication of further evidence into infracoccygeal sacropexy using mesh to repair uterine prolapse.

    Recommendation ID IPG582/1 Question Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life

    Research recommendation
    Published
    12 October 2018

  12. Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated or triclosan-impregnated sutures?

    Recommendation ID NG125/5 Question Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated

    Research recommendation
    Published
    16 August 2019

  13. Clinicians should collect data on all patients undergoing focal cryoablation (including details of case selection, methods of follow-up and outcomes) for local audit. Clinicians should enter details about all patients undergoing focal therapy using cryoablation for localised prostate cancer onto the European Registry for Cryosurgical Ablation of the Prostate (EuCAP) register and review clinical outcomes locally.

    Recommendation ID IPG423/2 Question Clinicians should collect data on all patients undergoing focal cryoablation (including details of

    Research recommendation
    Published
    9 June 2015

  14. What is the impact of coexisting physical health conditions on the mortality of people with complex psychosis?

    Recommendation ID NG181/8 Question What is the impact of coexisting physical health conditions on the mortality of people with complex

    Research recommendation
    Published
    26 October 2020

  15. Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with motor neurone disease (MND) on clinical practice, the person and their family and carers? Does repeated assessment provide more benefit than assessment at a single point at diagnosis?

    Recommendation ID NG42/2 Question Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with

    Research recommendation
    Published
    21 March 2016